Peptide antagonists at glutamate and NMDA receptors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Aug 22, 2002
app pub date -
Feb 26, 2002
filing date -
May 14, 1993
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Peptide antagonists of glutamate receptors and a subtype of glutamate receptors [NMDA(N-methyl-D-aspartate)receptors] influence glutamate receptor- and NMDA receptor-controlled cells, such as neurons or glial cells in the central nervous system; and can be used in the treatment of acute or chronic disorders of the central nervous system and the treatment of hypoxic, ischemic, and metabolic brain disorders.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully